Spot Trading’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
BC
KCM
RA
KCM
PAI
WVP
PAM
VMI
Spot Trading's ARCT Position: Q4 2014 in Review
Spot Trading sold out of Arcturus Therapeutics (ARCT) in Q4 2014, closing a stake of 2,355 shares — an estimated $254K sold.
Spot Trading first reported a position in ARCT in Q2 2014 and held it in 2 quarters. The position peaked at $318K in Q2 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q4 2014.
- Spot Trading reported no remaining Arcturus Therapeutics position as of Q4 2014 after selling out during the quarter.
- Spot Trading sold 2,355 Arcturus Therapeutics shares in Q4 2014, an estimated $254K.
- Spot Trading first reported a position in Arcturus Therapeutics in Q2 2014 and held it in 2 quarters.
- Spot Trading's Arcturus Therapeutics position peaked at $318K in Q2 2014.
- 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2014.
Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.